An adolescent, often referred to as a teenager, is an individual in the transitional stage of development between childhood and adulthood, typically spanning the ages of thirteen to nineteen years old. This developmental period is characterized by significant physical, cognitive, emotional, and social changes as adolescents navigate the transition from dependency on caregivers to greater independence and autonomy. Adolescents experience rapid growth and maturation, including pubertal changes such as the development of secondary sexual characteristics, hormonal fluctuations, and changes in body composition. Psychologically, adolescents undergo cognitive development, abstract thinking, identity formation, and exploration of personal values, beliefs, and goals. Socially, they form relationships with peers, establish social networks, and develop a sense of belonging and identity within peer groups. Adolescents also face increasing pressure to conform to societal norms, academic expectations, and peer influences while navigating challenges such as peer pressure, risk-taking behaviors, and identity exploration. Overall, adolescence is a dynamic and formative stage of development that shapes individuals' future health, relationships, and identity.
Hyperinsulinemia, insulin resistance, and metabolic syndrome are not typically implicated in the major disorders of adolescents such as mental health disorders, sexually transmitted infections (STIs), eating disorders, substance abuse, and reproductive health issues. These
etabolic abnormalities are more commonly associated with conditions that develop later in life, particularly in adulthood, and are influenced by factors such as genetics, lifestyle, and environmental exposures. However, promoting healthy metabolic habits from an early age is essential for reducing the risk of metabolic disorders in adulthood. This includes encouraging a balanced diet, regular physical activity, adequate sleep, and limiting exposure to environmental toxins. Additionally, addressing mental health concerns, promoting healthy relationships, providing comprehensive sexual education, and offering access to reproductive health services are crucial for supporting the overall health and well-being of adolescents. Regular medical check-ups and screening for risk factors are important for identifying and addressing any potential health concerns in adolescents.
Obesity rates among adolescents have been steadily increasing globally, posing a significant public health challenge. The prevalence of obesity in adolescence varies by region and country, with higher rates observed in developed countries and certain ethnic groups. Factors contributing to the rising prevalence of obesity in adolescence include changes in dietary habits, decreased physical activity, and environmental factors. Adolescent obesity increases the risk of various health complications, including metabolic disorders, cardiovascular diseases, and psychological issues. Preventive measures, such as promoting healthy lifestyles, encouraging physical activity, and addressing social determinants of health, are essential for mitigating the risk of obesity and promoting optimal health outcomes during adolescence.
Obesity in adolescence can have significant health implications, affecting both physical and psychological well-being. Adolescents with obesity are at increased risk of developing metabolic disorders, such as insulin resistance and dyslipidemia, which can lead to type 2 diabetes and cardiovascular disease later in life. Additionally, obesity in adolescence may lead to psychological issues, including poor self-esteem, depression, and social stigma. Long-term consequences of adolescent obesity include an increased risk of obesity-related chronic diseases and premature mortality in adulthood. Addressing obesity in adolescence through early intervention, lifestyle modifications, and comprehensive care is crucial for reducing the risk of these health complications and promoting long-term health and well-being.
" Did you know the American Academy of Pediatrics guidelines for obesity and metabolic disease recommend that a 13 year old child get bariatric surgery or an injection hormone to lose weight and reverse disease, but that a Low Carb Diet requires intense medical supervision? Given these biased and over-medicalized recommendations, a group of doctors including myself @doctorTro, @LauraBuchananMD,@MattCalkinsMD,@drericwestman Dr. Mark Cuccuzella, and
wrote a response to the editor. They actually refused to publish that response, so we submitted it to @TheSMHP
Journal of Metabolic Health What did our review find? They confused 4:1 ketogenic diets with well formulated low-carb diets They omitted data demonstrating the benefits of low-carb diets. They had ZERO authors who actually have clinical experience with low-carb diets. You can review our response paper: We argue that therapeutic carbohydrate reduction (TCR) for treating metabolic diseases in children should not be confused with 4:1 ketogenic diets used for epilepsy. We criticize the bias in current pediatric dietary guidelines which conflate the two, noting that TCR is safer and more nutrient-dense, making it suitable for managing conditions like diabetes and obesity in children without the risks typically associated with strict ketogenic diets. We also advocate for more flexible and inclusive dietary guidelines that recognize the benefits and safety of TCR.
" Recent reviews of using therapeutic carbohydrate reduction to treat metabolic disease in paediatric patients have consistently made errors in the form of bias against recommending this nutrient-dense eating pattern despite strong evidence for its use in adults and emerging evidence in paediatric patients. The purpose of this perspective is to review these errors, which include conflating 4:1 ketogenic diets with well-formulated ketogenic diets and the needless medicalisation of using therapeutic carbohydrate reduction in paediatric populations. "
The prevalence of type 2 diabetes in adolescence has been increasing in recent years, paralleling the rise in obesity rates and changes in lifestyle factors. While type 2 diabetes is less common in adolescence compared to adulthood, the incidence of early-onset diabetes is rising, particularly among certain ethnic groups and populations with a high prevalence of obesity. The rising prevalence of type 2 diabetes in adolescence underscores the importance of early detection, preventive measures, and lifestyle interventions to mitigate the risk of complications and optimize long-term health outcomes.
Type 2 diabetes in adolescence can have serious health consequences, affecting both physical and psychological well-being. Adolescents with diabetes require ongoing medical management, including blood glucose monitoring, insulin therapy, and dietary modifications, to maintain optimal health and prevent complications. Uncontrolled diabetes in adolescence can lead to short-term complications such as hypoglycemia, hyperglycemia, and diabetic ketoacidosis, which require prompt medical attention. Long-term implications of early-onset diabetes may include an increased risk of obesity-related chronic diseases, cardiovascular disease, and kidney disease in adulthood. Early diagnosis, comprehensive care, and ongoing monitoring are essential for managing type 2 diabetes in adolescence and promoting optimal health outcomes throughout life.
Obesity indices and lipid/lipoprotein fractions are significantly associated risk factors with IR andmight be used as significant indicators formetabolic complications among obeseadolescents
(PDF) Risk factors predicting insulin resistance in obese adolescents.
Available from: https://www.researchgate.net/publication/370107229_Risk_factors_predicting_insulin_resistance_in_obese_adolescents#fullTextFileContent [accessed Mar 18 2024].
Our study provides evidence that children with se veral components of MS mainly have a inflammatory state and/or IR, appearing even before meeting the ful filled diagnostic criteria, with an adequate number of studied subjects, conducted prospectively and simulta neously measuring physical and biochemical parame ters. Our population segment has a high percentage of obesity. This does not invalidate our results, because our study does not attempt to know MS prevalence, but rather of the correlation of its components with new markers of early endothelial damage. Studies with a representative sample of the general population may be able to reduce bias and determi ne the normal levels of these markers in pediatric age, since they could be a useful tool for determining the presence of endothelial inflammation in children and in the future could be helpful to properly estimate car diometabolic risk in our children
Insulin resistance is highly prevalent in obese children and adolescents. The onset of Impaired Glucose Tolerance, ( IGT () is associated with the development of severe hyperinsulinemia as there are no predictive cutpoint values of insulin resistance or insulin sensitivity indexes for IGT, and neither fasting blood glucose nor insulin levels nor HOMA-IR or HOMA %B are effective screening tools; an OGTT is required in all subjects at high risk. Longitudinal studies are needed to identify the metabolic precursors and the natural history of the development of type 2 diabetes in these patients.
Oral glucose tolerance tests (OGTT) are used to measure how well the body can process a larger amount of sugar. If the blood sugar measured in the test is above a certain level, this could be a sign that sugar is not being absorbed enough by the body’s cells. Diabetes or gestational diabetes might be at the root of this problem.
In gestational diabetes, blood sugar levels are often higher due to changes in the metabolism during pregnancy – but they usually come back down again after the child is born.
There are two types of glucose tolerance tests: a short version called the glucose challenge test, and a full glucose tolerance test. The short version is easier to do and serves as a preliminal test to determine someone's risk of diabetes or gestational diabetes.
The glucose challenge test is the short version of the glucose tolerance test. The test can be done at any time of the day. It involves drinking a glass of concentrated glucose solution (50 g of glucose dissolved in 250 to 300 ml of water). After one hour has passed, a blood sample is taken to determine the blood sugar level.
For this test, you should not eat anything before going to the doctor in the morning. In other words, you should not have breakfast, and you should eat your last meal the evening before. This also applies to all drinks with the exception of water.
First of all, blood is taken to determine your baseline blood sugar level. The blood is drawn from a vein or your fingertip or earlobe. After that you drink a large glass of concentrated sugar solution. In the glucose tolerance test, 75 g of glucose are dissolved in 250 to 300 ml of water. The amount given to children is based on their body weight. If the test is being done to confirm suspected diabetes, blood is drawn again after two hours and the blood sugar level is measured. When testing for gestational diabetes, blood is drawn twice – first after one hour and then again after another two hours.
It is recommended that you do the test while lying down or sitting, and do not eat, drink or smoke until the last blood sample is taken. It is also important that you maintain a normal, balanced diet in the days leading up to the test. Major changes in your eating habits, like going on a diet, can influence the results of the test and make them less reliable. Some medications can al
"Obesity is a hazard mark that associated with insulin resistance (IR). This study aimed to detect which risk factors might provide the greatest predictive value for IR in obese adolescents aged thirteen to seventeen years. One hundred obese adolescents with IR and matched age and sex 100 obese healthy controls without IR were included. Anthropometry, serum lipids and metabolic biomarkers were measured. Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) was used to determine insulin Resistance. Significant increase in serum lipids and metabolic parameters in obese cases with IR compared to those without. Positive correlations were observed between obesity measurements and metabolic risk markers, including increase of waist to hip ratio (WHR), sum of skin folds, blood pressure, insulin, HOMA-IR, TC, TG and LDL-C levels and decrease of HDL-C in IR adolescents. WHR showed the highest correlations with biochemical markers in IR cases. WHR was able to predict IR with area under the curve = 0.82 and TG-to-HDL-C ratio with area under the curve = 0.87. WHR and lipid/lipoprotein fractions are significantly associated with IR in obese adolescents and might be used for the prediction of IR and for cases at high risk for early intervention.
The results suggested that adolescents with PCOS have more than three times the odds of having MetS than controls (OR 3.32, 95% CI [2.14, 5.14]). Obese adolescents with PCOS also had a higher risk of MetS than those with obesity but without PCOS (OR 3.97, 95% CI [1.49, 10.53]). Compared to those without PCOS, systolic blood pressure was higher in adolescents with PCOS (weighted mean difference (WMD) 3.85, 95% CI [1.73, 5.97]), while diastolic blood pressure was higher only in girls with PCOS who had a normal weight (WMD 3.52, 95% CI [1.57, 5.48]). The levels of triglycerides were higher in obese adolescents with PCOS than in those with obesity but without PCOS (WMD 27.84, 95% CI [10.16, 45.51]). PCOS could increase the frequency of MetS by influencing blood pressure and lipid metabolism independent of obesity as early as the adolescent period. Thus, clinicians should perform early interventions in adolescents with PCOS and follow up the relevant indicators of MetS to decrease the risk of poor long-term prognosis.
"High levels of serum uric acid, UAR, UCR, and UHR were associated with obesity. Furthermore, we found that uric acid, UAR, and UHR were positively correlated with insulin resistance".
" The increase in serum uric acid showed a positive statistical correlation with insulin resistance and it is associated with and increased risk of insulin resistance in obese children and adolescents. "
" Our study provides evidence that children with several components of MS mainly have a inflammatory state and/or IR, appearing even before meeting thefull diagnostic criteria, "
fasting blood sugars may be normal but look at fasting insulin
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Copyright © 2024 Metabolic Health Malta - All Rights Reserved.
metabolichealthmalta.com
disclaimer The views and opinions expressed on this site are solely those of the contributing individuals and authors, and in no way reflect or represent the position of the authors' employers, management, shareholders or other employees thereof. All data and information provided on this site is for informational purposes only. We make no representations as to accuracy, completeness, currentness, suitability, or validity of any information on this site and will not be liable for any errors, omissions, or delays in this information or any losses, injuries, or damages arising from its display or use. All information is provided on an as-is basis.
We do not provide medical advice. All individuals should seek personal medical assistance in considering adopting any personal diet. No responsibility can be taken for any actions taken by anyone including health professionals, social media or personal health.
Powered by GoDaddy